ArticleIntestinal research2021

Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis.

Taku Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.